Tergene Biotech Profile
Key Indicators
- Authorised Capital ₹ 46.00 Cr
- Paid Up Capital ₹ 44.55 Cr
- Company Age 17 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.18 Cr
- Revenue Growth 107.03%
- Profit Growth 20.31%
- Ebitda -43.79%
- Net Worth -20.43%
- Total Assets -27.80%
About Tergene Biotech
Tergene Biotech Limited (TBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 07 March 2008 and has a history of 17 years and three months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Tergene Biotech Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 46.00 Cr and a paid-up capital of Rs 44.55 Cr.
The company has closed loans amounting to ₹1.18 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Tergene Biotech Limited India are Vijayudu Gajulapalli as COMPANY SECRETARY and Lonkari Sudhakar as Cfo. Mosuvan Kuppusamy, Sivakumaran Meenakshisunderam, Kuppusamy Sathyan, and Two other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230TG2008PLC113178
- Company No.
113178
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Mar 2008
- Date of AGM
21 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Life Sciences
Tergene Biotech Limited
Explore comprehensive data for Tergene Biotech Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Tergene Biotech?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijayudu Gajulapalli  | Company Secretary | 12-Jun-2024 | Current |
| Lonkari Sudhakar | CFO | 21-Mar-2022 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mosuvan Kuppusamy | Director | 07-Mar-2008 | Current |
| Sivakumaran Meenakshisunderam | Director | 01-Apr-2015 | Current |
| Kuppusamy Sathyan | Director | 07-Mar-2008 | Current |
| Santhanam Subramanian | Director | 26-Aug-2016 | Current |
| Umesh Krishnamoorthy | Director | 28-Jun-2023 | Current |
Financial Performance of Tergene Biotech.
Tergene Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 107.03% increase. The company also saw a substantial improvement in profitability, with a 20.31% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tergene Biotech?
In 2023, Tergene Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eugia Pharma Specialities LimitedSanthanam Subramanian is a mutual person
Curateq Biologics Private LimitedSivakumaran Meenakshisunderam is a mutual person
- Auro Peptides Limited
Sivakumaran Meenakshisunderam is a mutual person
- Apl Healthcare Limited
Sivakumaran Meenakshisunderam is a mutual person
- Eugia Steriles Private Limited
Sivakumaran Meenakshisunderam and Santhanam Subramanian are mutual person
- Aurobindo Pharma Foundation
Sivakumaran Meenakshisunderam is a mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹1.18 Cr
Charges Breakdown by Lending Institutions
- Biotechnology Industry Research Assistance Council : 1.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2012 | Biotechnology Industry Research Assistance Council | ₹1.18 Cr | Satisfied |
How Many Employees Work at Tergene Biotech?
Unlock and access historical data on people associated with Tergene Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tergene Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tergene Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Tergene Biotech
Recent activity within the organization
- Director Appointment
Vijayudu Gajulapalli was appointed as a Company Secretary was appointed as a Company Secretary on 12 Jun 2024 & has been associated with this company since 1 year 6 days .
- Annual General Meeting
Tergene Biotech Limited last Annual general meeting of members was held on 21 Aug 2023 as per latest MCA records.
- Balance Sheet
Tergene Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Charges
A charge registered on 30 Aug 2012 via Charge ID 10373010 with Biotechnology Industry Research Assistance Council was fully satisfied on 15 Nov 2021.
- Director Appointment
Santhanam Subramanian was appointed as a Director was appointed as a Director on 26 Aug 2016 & has been associated with this company since 8 years 9 months .
- Director Appointment
Sivakumaran Meenakshisunderam was appointed as a Director was appointed as a Director on 01 Apr 2015 & has been associated with this company since 10 years 2 months .
Recent News, Updates & Announcement
Frequently asked questions
What is the Incorporation or founding date of Tergene Biotech Limited?
Tergene Biotech Limited was incorporated on 07 Mar 2008.
What is authorized share capital and paid-up capital of Tergene Biotech Limited?
The authorized share capital of Tergene Biotech Limited is ₹ 46.00 Cr and paid-up capital is ₹ 44.55 Cr.
Who are the current board members & directors of Tergene Biotech Limited?
Currently 7 directors are associated with Tergene Biotech Limited.
- Mosuvan Kuppusamy
- Sivakumaran Meenakshisunderam
- Kuppusamy Sathyan
- Santhanam Subramanian
- Umesh Krishnamoorthy
- Vijayudu Gajulapalli
- Lonkari Sudhakar
What is the registered address of Tergene Biotech Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Tergene Biotech Limited is Galaxy Floors 22-24 Plot No. 1 Survey 83/1 Knowledge City, Raidurg Panmak Tha India, Hyderabad, Telangana, 500032.
What is the corporate identification number (CIN) and company number of Tergene Biotech Limited?
The corporate identification number (CIN) of Tergene Biotech Limited is U24230TG2008PLC113178 and the company number is 113178 as per Ministry of Corporate Affairs (MCA).
What is the official website of Tergene Biotech Limited?
The Official website of Tergene Biotech Limited is https://www.tergene.com
What has been the recent revenue trend for Tergene Biotech Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Tergene Biotech Limited has risen by 107.03%.
What change has been observed in the net worth of Tergene Biotech Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Tergene Biotech Limited has experienced an downturn of -20.43%.
When was the last Balance Sheet of Tergene Biotech Limited filed with the ROC?
The most recent Balance Sheet for Tergene Biotech Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
JG
Jeyaram GunasekaranDirectorSP
Sarath PenakaDirectorSG
Swapna GunasekaranDirectorJK
Jayant KarajgiDirectorSM
Satakarni MakkapatiDirector
Similar Companies Based on Biotechnology
Venkateshwara B.V. Biocorp Private Limited Pune, Maharashtra, India
Sanofi Healthcare India Private Limited Mumbai, Maharashtra, India
Biotechnology Industry Research Assistance Council Delhi, India
Invitrogen Bioservices India Private Limited Bangaluru, Karnataka, India
Ecso Global Private Limited New Delhi, India
Gennova Biopharmaceuticals Limited Pune, Maharashtra, India
Aurigene Oncology Limited Bangaluru, Karnataka, India